Samumed
-
Biologics
Samumed Phase 2b Trial in Knee Osteoarthritis Meets Primary Endpoints
SAN DIEGO, Oct. 24, 2018 (GLOBE NEWSWIRE) — Samumed announced today top-line data from its phase 2b trial of SM04690…
Read More » -
Biologics
Samumed’s Osteoarthritis Research Selected for an Oral Presentation at a Gordon Research Conference
August 01, 2017 SAN DIEGO–(BUSINESS WIRE)–Samumed, a leader in Wnt research and development, has been selected for an oral presentation…
Read More » -
Biologics
Samumed Successfully Completed 52-Week Phase 2 Study for Treatment of Osteoarthritis of the Knee
July 27, 2017 SAN DIEGO–(BUSINESS WIRE)–Samumed, a leader in cartilage regeneration research, today announced the successful completion of a 52-week…
Read More »